Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats

J. Kassa, JZ. Karasova, S. Tesarova

. 2011 ; 34 (3) : 233-9.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

The ability of two combinations of oximes (HI-6+trimedoxime, HI-6+K203) to reduce soman-induced acute neurotoxic signs and symptoms was compared with the neuroprotective efficacy of the oxime HI-6 alone, using a functional observational battery. Soman-induced neurotoxicity and the neuroprotective effects of HI-6 alone and HI-6 combined with trimedoxime or K203 in rats poisoned with soman at a sublethal dose (90 μg/kg intramuscularly, i.m.; 80% of LD₅₀ value) were monitored by the functional observational battery at 24 hours following soman administration. The results indicate that both tested oxime mixtures combined with atropine were able to allow soman-poisoned rats to survive 24 hours following soman challenge, while 4 nontreated soman-poisoned rats and 1 soman-poisoned rat treated with oxime HI-6 alone combined with atropine died within 24 hours following soman poisoning. While the oxime HI-6 alone combined with atropine treatment was able to eliminate a few soman-induced neurotoxic signs and symptoms, both oxime mixtures showed higher neuroprotective efficacy in soman-poisoned rats. Especially, the combination of HI-6 with trimedoxime was able to eliminate most soman-induced neurotoxic signs and symptoms and markedly reduce acute neurotoxicity of soman in rats. Thus, both tested mixtures of oximes combined with atropine were able to increase the neuroprotective effectiveness of antidotal treatment of acute soman poisonings, compared to the individual oxime.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12028271
003      
CZ-PrNML
005      
20121207094954.0
007      
ta
008      
120817s2011 enk f 000 0#eng||
009      
AR
024    7_
$a 10.3109/01480545.2010.510525 $2 doi
035    __
$a (PubMed)21649476
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kassa, Jiří, $d 1956- $7 mzk2003181395 $u Department of Toxicology, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic.
245    12
$a A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats / $c J. Kassa, JZ. Karasova, S. Tesarova
520    9_
$a The ability of two combinations of oximes (HI-6+trimedoxime, HI-6+K203) to reduce soman-induced acute neurotoxic signs and symptoms was compared with the neuroprotective efficacy of the oxime HI-6 alone, using a functional observational battery. Soman-induced neurotoxicity and the neuroprotective effects of HI-6 alone and HI-6 combined with trimedoxime or K203 in rats poisoned with soman at a sublethal dose (90 μg/kg intramuscularly, i.m.; 80% of LD₅₀ value) were monitored by the functional observational battery at 24 hours following soman administration. The results indicate that both tested oxime mixtures combined with atropine were able to allow soman-poisoned rats to survive 24 hours following soman challenge, while 4 nontreated soman-poisoned rats and 1 soman-poisoned rat treated with oxime HI-6 alone combined with atropine died within 24 hours following soman poisoning. While the oxime HI-6 alone combined with atropine treatment was able to eliminate a few soman-induced neurotoxic signs and symptoms, both oxime mixtures showed higher neuroprotective efficacy in soman-poisoned rats. Especially, the combination of HI-6 with trimedoxime was able to eliminate most soman-induced neurotoxic signs and symptoms and markedly reduce acute neurotoxicity of soman in rats. Thus, both tested mixtures of oximes combined with atropine were able to increase the neuroprotective effectiveness of antidotal treatment of acute soman poisonings, compared to the individual oxime.
650    _2
$a zvířata $7 D000818
650    _2
$a chování zvířat $x účinky léků $7 D001522
650    _2
$a kombinovaná farmakoterapie $7 D004359
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a molekulární struktura $7 D015394
650    _2
$a pohybová aktivita $x účinky léků $7 D009043
650    _2
$a neuroprotektivní látky $x aplikace a dávkování $x chemie $x terapeutické užití $7 D018696
650    _2
$a neurotoxické syndromy $x etiologie $x patofyziologie $x prevence a kontrola $7 D020258
650    _2
$a oximy $x aplikace a dávkování $x chemie $x terapeutické užití $7 D010091
650    _2
$a pyridinové sloučeniny $x aplikace a dávkování $x chemie $x terapeutické užití $7 D011726
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a soman $x otrava $7 D012999
650    _2
$a trimedoxim $x aplikace a dávkování $x chemie $x terapeutické užití $7 D014289
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Žďárová Karasová, Jana, $d 1982- $7 xx0099787
700    1_
$a Tesařová, Sandra $7 xx0109646
773    0_
$w MED00001436 $t Drug and chemical toxicology $x 1525-6014 $g Roč. 34, č. 3 (2011), s. 233-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21649476 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121207095028 $b ABA008
999    __
$a ok $b bmc $g 950313 $s 785617
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 34 $c 3 $d 233-9 $i 1525-6014 $m Drug and chemical toxicology $n Drug Chem Toxicol $x MED00001436
LZP    __
$a Pubmed-20120817/11/04

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...